Blood Screening Market Size, Share & Trends Report

Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-215-0
Number of Pages: 90
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Nucleic Acid Amplification Test (NAT)
- ELISA
- Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- Next Generation Sequencing (NGS)
- Western Blotting
Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagent
- Instrument
Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    - Next Generation Sequencing (NGS)
    - Western Blotting
  - North America Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent
    - Instrument
  - U.S.
    - U.S. Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - U.S. Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Canada
    - Canada Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Canada Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
- Europe
  - Europe Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    - Next Generation Sequencing (NGS)
    - Western Blotting
  - Europe Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent
    - Instrument
  - UK
    - UK Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - UK Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Germany
    - Germany Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Germany Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - France
    - France Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - France Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Italy
    - Italy Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Italy Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Spain
    - Spain Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Spain Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Sweden
    - Sweden Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Sweden Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Norway
    - Norway Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Norway Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Denmark
    - Denmark Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Denmark Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
- Asia Pacific
  - Asia Pacific Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    - Next Generation Sequencing (NGS)
    - Western Blotting
  - Asia Pacific Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent
    - Instrument
  - Japan
    - Japan Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Japan Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - China
    - China Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - China Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - India
    - India Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - India Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Australia
    - Australia Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Australia Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Thailand
    - Thailand Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Thailand Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - South Korea
    - South Korea Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - South Korea Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
- Latin America
  - Latin America Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    - Next Generation Sequencing (NGS)
    - Western Blotting
  - Latin America Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent
    - Instrument
  - Brazil
    - Brazil Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Brazil Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Mexico
    - Mexico Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Mexico Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Argentina
    - Argentina Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Argentina Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
- Middle East and Africa
  - Middle East and Africa Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    - Next Generation Sequencing (NGS)
    - Western Blotting
  - Middle East and Africa Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagent
    - Instrument
  - South Africa
    - South Africa Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - South Africa Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Saudi Arabia
    - Saudi Arabia Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Saudi Arabia Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - UAE
    - UAE Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - UAE Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument
  - Kuwait
    - Kuwait Blood Screening Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next Generation Sequencing (NGS)
      - Western Blotting
    - Kuwait Blood Screening Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagent
      - Instrument

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.